MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. ROIV
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Roivant Sciences (ROIV) Financial Metrics 2021-2026

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$35.13
248.2%
Market Cap
$25.20B
253.0%

ROIV trades at $35.13, a 248.2% increase year-over-year. Market capitalization stands at $25.20B, up 253.0% from the prior year. Track ROIV price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$8.26M
71.6%
Q. Revenue
$2.52M
TTM EBITDA
$-510.11M
48.0%
TTM Op. Income
$-515.07M
48.7%
Q. Op. Income
$415.24M
TTM Net Income
$-299.77M
74.3%
Q. Net Income
$302.99M
EPS
$0.422
Shares Out.
$717.36M
1.4%
$8.26M in TTM revenue declined 71.6% YoY, reaching $2.52M last quarter. TTM EBITDA of $-510.11M and TTM operating income of $-515.07M shows growth is flowing through. However, net income is negative at $299.77M — growth is not yet reaching the bottom line. Revenue is contracting — assess whether this is cyclical or structural.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets
$5.71B
Cash
$1.42B
Long-Term Debt
N/A
Book Value
$4.53B
D/E Ratio
N/A
Debt/EBITDA
0.0
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Book Value (Equity)
Growing book value signals intrinsic value creation
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$-163.82M
Free Cash Flow
$-165.08M
4.8%
FCF Margin
-1998.5%
FCF / Net Income
-0.5
FCF of $-165.08M on $-163.82M in operating cash flow. The FCF / Net Income ratio of 0.6x indicates partial cash conversion — earnings quality needs attention.
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (%)
10%+ signals a capital-efficient business model
FCF / Net Income
Above 1 means earnings are backed by real cash

Margins

Profit margins across the income statement

EBITDA Margin
16567.1%
Op. Margin
16477.8%
2342.0%
Net Margin
12023.6%
2204.4%
Op. margin of 16477.8% is up 15803.0% YoY — cost efficiency is improving. Net margin at 12023.6%.
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit

Price Ratios

Valuation multiples — is the company cheap or expensive?

P/E Ratio
N/A
P/S Ratio
3051.0x
P/B Ratio
5.6x
P/S of 3051.0x and P/B of 5.6x. A high P/S suggests growth expectations are priced in.
P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (%)
Cash return at current price — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E

Others

Return ratios, efficiency, and credit metrics

ROE
-6.6%
ROA
-5.3%
Asset Turnover
0.0
Rev/Share
$0.01
ROA of -5.3% shows how efficiently management uses assets to generate profit. Revenue per share at $0.012 removes dilution effects from top-line growth.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments